GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 2 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $15,000 | +114.3% | 214 | 0.0% | 0.00% | – |
Q2 2022 | $7,000 | 0.0% | 214 | 0.0% | 0.00% | – |
Q1 2022 | $7,000 | +16.7% | 214 | 0.0% | 0.00% | – |
Q4 2021 | $6,000 | +20.0% | 214 | 0.0% | 0.00% | – |
Q3 2021 | $5,000 | +25.0% | 214 | +84.5% | 0.00% | – |
Q2 2021 | $4,000 | -20.0% | 116 | 0.0% | 0.00% | – |
Q1 2021 | $5,000 | 0.0% | 116 | 0.0% | 0.00% | – |
Q4 2020 | $5,000 | -73.7% | 116 | -66.7% | 0.00% | – |
Q3 2020 | $19,000 | +11.8% | 348 | +2.4% | 0.00% | – |
Q2 2020 | $17,000 | 0.0% | 340 | 0.0% | 0.00% | – |
Q1 2020 | $17,000 | -37.0% | 340 | 0.0% | 0.00% | – |
Q4 2019 | $27,000 | +42.1% | 340 | -11.0% | 0.00% | – |
Q3 2019 | $19,000 | 0.0% | 382 | +6.7% | 0.00% | – |
Q2 2019 | $19,000 | 0.0% | 358 | 0.0% | 0.00% | – |
Q1 2019 | $19,000 | +90.0% | 358 | +48.5% | 0.00% | – |
Q4 2018 | $10,000 | +11.1% | 241 | 0.0% | 0.00% | – |
Q3 2018 | $9,000 | -18.2% | 241 | 0.0% | 0.00% | – |
Q2 2018 | $11,000 | -8.3% | 241 | 0.0% | 0.00% | – |
Q1 2018 | $12,000 | – | 241 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |